SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EARNINGS FLASH L impact

Cue Biopharma Q3 net loss widens on higher R&D costs

Cue Biopharma Q3 net loss widens on higher R&D costs Overview US biopharma's Q3 revenue dropped shar

CUE

Related stories